Pay in 4 interest-free payments of $18.75 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
CNX-1351 inhibit PI3Kα signaling in cells and shows prolonged inhibition consistent with a covalent mechanism of Action
the APAP was adminstrated intramuscularly once a day for 3 days
Formula: C15H16N3NaO4S
Solubility: DMSO: 100 mg/mL(108
Meropenem (trihydrate) - CAS# 119478-56-7 ol hydrate) CNX-1351 inhibit PI3Kα signaling inMeropenem is an ultra broad spectrum injectable antibiotic used to treat a wide variety of infections, including meningitis and pneumonia. It is a beta lactam and belongs to the subgroup of carbapenem, similar to imipenem and ertapenem. Meropenem was originally developed by Sumitomo Pharmaceuticals. It is marketed outside Japan by AstraZeneca with the brand names Merrem and Meronem. Other brand names include Zwipen (India, Marketed by Nucleus) Mepem
US$ 49000.00
US$ 93500.00
US$ 66000.00
US$ 99000.00
US$ 148500.00
US$ 99000.00
US$ 110000.00
US$ 165000.00
US$ 93500.00
US$ 220000.00
US$ 165000.00
US$ 71500.00